Considering that CSF samples gave more discordant results between commercial and in-house IIFAs and CSF antibody detection is crucial for the diagnosis of autoimmune encephalitis, we assessed 54 additional CSF samples of patients with encephalitis and GABABR, LGI1 or AMPAR antibodies, confirmed by brain immunohistochemistry and in-house IIFA, and retested them by commercial IIFA (Cohort B). This evidence concerns the gene LGI1 and encephalitis.